Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Patients(BCS) With Digestive Tract .
Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
The efficacy and safety of cancer patients in patients with gastrointestinal cancer
(Palliative care) in patients with gastrointestinal tumor (chemotherapy) were prospectively,
randomized blind, multicenter clinical trials. They were randomly divided into 2 groups, test
group Shenqifuzheng injection of 500 ml, the control group 0.9% sodium chloride injection,
500 ml, intravenous drip, 1 times a day, 14 days post, rest is 7 days, 21 days each for a
period of treatment, observation of two procedures. At the same time, according to the NCCN
guide and the health ministry issued the diagnosis and treatment guidelines for cancer
treatment. The main curative effect of the clinic was to evaluate the pretreatment of cancer
due to the fatigue score of the patients before and after treatment -- the Piper fatigue
revision scale was used to evaluate the Chinese version. Assess effectiveness and safety
based on clinical assessment